Fig. 3From: Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapyChemical structures of dual VEGFR2–EGFR inhibitors 14, 16, 17 and 19–25 and their inhibitory activities against VEGFR2 and EGFRBack to article page